HEPLISAV‑B is the only adult hepatitis B vaccine that provides protection with only 2 doses in 1 month
City, state, or ZIP code
To find a participating pharmacy, use the search feature and select your pharmacy either in the search results or by using the map.
No results found
Your search did not return any results.
Inclusion of pharmacy information in this finder is based on available data at the time of posting and does not guarantee supply, nor does it represent an endorsement, referral, or recommendation from Dynavax. Please be sure to contact the pharmacy of your choice to check their availability of HEPLISAV‑B.
*For most people, hepatitis B clears on its own. For those who don’t clear the virus, the resulting health complications can be lifelong or even deadly. There is no way of definitively knowing who will clear the virus and who will not.
†The CDC recommends hepatitis B vaccination for all adults aged 19–59 and for adults aged ≥60 years with risk factors. Adults aged ≥60 years without risk factors may receive hepatitis B vaccination. This recommendation applies to adults who have not received a complete hepatitis B vaccine series in their lifetime.
CDC=Centers for Disease Control and Prevention
This site uses cookies to improve your experience. By continuing to use this website you are agreeing to our Cookie Policy.
This site uses cookies to improve your experience. By continuing to use this website you are agreeing to our Cookie Policy.
HEPLISAV‑B is a shot given to adults 18 years of age and older to help prevent infection caused by the hepatitis B virus.
HEPLISAV‑B is usually given in the arm muscle. HEPLISAV‑B is given in 2 doses, 1 month apart, by a healthcare provider.
IMPORTANT SAFETY INFORMATION
If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV‑B, including yeast, do not take HEPLISAV‑B.
HEPLISAV‑B must be given by a medical professional, who will monitor you afterwards, to check for allergic reaction.
If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV‑B.
Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV‑B may not prevent hepatitis B infection.
The most common side effects include pain at the injection site, tiredness, and headache.
HEPLISAV‑B was not studied in pregnant or nursing women. Tell your provider if you are pregnant or plan to become pregnant or are breast feeding.
Vaccination with HEPLISAV‑B may not protect all individuals.
Talk to your healthcare provider to determine if HEPLISAV‑B is right for you.
ADDITIONAL IMPORTANT INFORMATION
HEPLISAV‑B does not treat liver diseases such as cirrhosis or liver cancer.
Not all liver cancer is caused by the hepatitis B virus.
